Total Payments
$2,002
2024 Payments
$482.71
Companies
19
Transactions
104
Medicare Patients
4,167
Medicare Billing
$508,690
Payment Breakdown by Category
Food & Beverage$1,870 (93.4%)
Gifts$124.84 (6.2%)
Education$6.61 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,870 | 101 | 93.4% |
| Gift | $124.84 | 2 | 6.2% |
| Education | $6.61 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $755.50 | 48 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $174.98 | 13 | $0 (2023) |
| Braintree Laboratories, Inc. | $148.16 | 3 | $0 (2021) |
| Celgene Corporation | $126.25 | 7 | $0 (2024) |
| ABIOMED | $118.25 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $99.44 | 4 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $94.85 | 4 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $84.06 | 5 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $75.39 | 3 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $65.17 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $482.71 | 24 | ABBVIE INC. ($160.71) |
| 2023 | $423.81 | 18 | ABIOMED ($118.25) |
| 2022 | $460.01 | 28 | ABBVIE INC. ($245.77) |
| 2021 | $565.14 | 32 | AbbVie Inc. ($263.07) |
| 2020 | $69.83 | 2 | Braintree Laboratories, Inc. ($53.32) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Immunology | ||||||
| 09/12/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/10/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $15.39 | General |
| 08/30/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 08/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: Immunology | ||||||
| 07/16/2024 | VIVUS LLC | QSYMIA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/23/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/03/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/11/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Oncology | ||||||
| 03/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: IMMUNOLOGY | ||||||
| 02/29/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: GASTROENTEROLOGY | ||||||
| 01/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.86 | General |
| Category: Neuroscience | ||||||
| 12/13/2023 | NESTLE HEALTHCARE NUTRITION INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,457 | 1,781 | $507,978 | $173,372 |
| 2022 | 14 | 1,336 | 1,590 | $443,145 | $154,975 |
| 2021 | 14 | 1,319 | 1,658 | $470,337 | $177,033 |
| 2020 | 1 | 55 | 55 | $6,160 | $3,310 |
Total Patients
4,167
Total Services
5,084
Medicare Billing
$508,690
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 186 | 192 | $89,280 | $38,043 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 405 | 601 | $67,312 | $37,420 | 55.6% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 52 | 142 | $74,550 | $30,750 | 41.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 274 | 278 | $125,100 | $21,178 | 16.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 225 | 225 | $36,900 | $16,795 | 45.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 158 | 170 | $72,250 | $11,238 | 15.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 53 | 55 | $19,131 | $6,570 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 37 | $6,068 | $3,320 | 54.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $5,332 | $3,316 | 62.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 22 | $2,449 | $1,388 | 56.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,730 | $1,353 | 49.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $4,950 | $1,219 | 24.6% |
| 45331 | Biopsy of lower large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $1,926 | $782.03 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 358 | 507 | $56,784 | $32,919 | 58.0% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 50 | 133 | $69,825 | $29,903 | 42.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 139 | 140 | $65,100 | $27,369 | 42.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 241 | 243 | $109,350 | $18,558 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 242 | 242 | $39,688 | $18,281 | 46.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 145 | 156 | $62,600 | $10,735 | 17.1% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 57 | 58 | $15,429 | $6,394 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $5,727 | $2,824 | 49.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $3,259 | $1,745 | 53.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 17 | $2,788 | $1,574 | 56.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $2,940 | $1,513 | 51.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 12 | 13 | $5,850 | $1,508 | 25.8% |
About Dr. Madhavi Ravi, M.D
Dr. Madhavi Ravi, M.D is a Gastroenterology healthcare provider based in Summerfield, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/05/2014. The National Provider Identifier (NPI) number assigned to this provider is 1861818510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Madhavi Ravi, M.D has received a total of $2,002 in payments from pharmaceutical and medical device companies, with $482.71 received in 2024. These payments were reported across 104 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,870).
As a Medicare-enrolled provider, Ravi has provided services to 4,167 Medicare beneficiaries, totaling 5,084 services with total Medicare billing of $508,690. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Summerfield, FL
- Active Since 03/05/2014
- Last Updated 07/07/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1861818510
Products in Payments
- LINZESS (Drug) $403.58
- ZENPEP (Drug) $159.45
- XIFAXAN (Drug) $159.32
- SUPREP BOWEL PREP (Drug) $124.84
- Impella (Device) $118.25
- DUPIXENT (Biological) $117.65
- ZEPOSIA (Drug) $103.99
- OCALIVA (Drug) $94.85
- HUMIRA (Biological) $93.66
- CREON (Drug) $79.77
- VIBERZI (Drug) $76.86
- ENTYVIO (Biological) $72.60
- RINVOQ (Biological) $57.40
- SKYRIZI (Biological) $44.23
- Linzess (Drug) $37.35
- GI GENIUS (Device) $30.16
- MOTEGRITY (Drug) $26.84
- SUTAB (Drug) $23.32
- RUCONEST (Biological) $20.18
- Cologuard Collection Kit (Device) $19.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.